A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets
Clinical trial NCT03684265 · COMPLETED
Trial details
- NCT number
- NCT03684265
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-05
- Primary completion
- 2018-10-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.